Literature DB >> 9328456

Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.

M G Cipolleschi1, G D'Ippolito, P A Bernabei, R Caporale, R Nannini, M Mariani, M Fabbiani, P Rossi-Ferrini, M Olivotto, P Dello Sbarba.   

Abstract

Incubation in severe hypoxia (1% oxygen) increased the number of erythroid bursts generated from full-term CD34+, or premature mononucleated, human cord blood (CB) cells, in semisolid cultures containing stem cell factor (SCF), interleukin (IL)-3 and erythropoietin (EPO). Severe hypoxia also enhanced the maintenance of erythroid burst-forming units (BFU-E) in CB cell liquid cultures. These positive effects of hypoxia on the maintenance and cloning efficiency of BFU-E did not extend to the other progenitors assayed. Hypoxia, on the other hand, markedly reduced the size and level of hemoglobinization of bursts and, in liquid cultures, suppressed the growth factor-stimulated numerical increase in BFU-E and inhibited the expression of CD36, a marker of erythroid colony-forming units and maturing erythroid precursors. However, when transferred to clonal assays incubated in air, cells from liquid cultures incubated in hypoxia or in air generated fully expanded and hemoglobinized bursts, suggesting that in hypoxia the clonogenic potential of BFU-E was maintained and the development of erythroid clones reversibly inhibited. These results indicate that hypoxia inversely regulates two subsequent phases of erythropoiesis, i.e., it enhances the maintenance of BFU-E and the early development of erythroid clones but inhibits the terminal expansion and maturation of these clones. The cloning of CB cells selected for CD34 positivity, when compared with that of the total population of mononucleated CB cells, revealed that the early development of erythroid bursts was either hypoxia-enhanced or hypoxia-insensitive, reflecting the existence of two different types of BFU-E. Hypoxia-enhanced BFU-E are relatively immature, are maintained in hypoxia but not in air, and account for a large part of CD34+ BFU-E and for a high percentage of the BFU-E in premature CB. Hypoxia-insensitive BFU-E are mostly CD34- and are largely predominant in full-term CB, and most probably correspond to a more mature type of BFU-E.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328456

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  14 in total

1.  BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors.

Authors:  John M Perry; Omid F Harandi; Robert F Paulson
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

2.  Human adipose tissue contains erythroid progenitors expressing fetal hemoglobin.

Authors:  Amparo Navarro; Francisco Carbonell-Uberos; Severiano Marín; María Dolores Miñana
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

3.  Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential.

Authors:  Swapna Panuganti; Eleftherios T Papoutsakis; William M Miller
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

4.  A genetic mechanism for Tibetan high-altitude adaptation.

Authors:  Felipe R Lorenzo; Chad Huff; Mikko Myllymäki; Benjamin Olenchock; Sabina Swierczek; Tsewang Tashi; Victor Gordeuk; Tana Wuren; Ge Ri-Li; Donald A McClain; Tahsin M Khan; Parvaiz A Koul; Prasenjit Guchhait; Mohamed E Salama; Jinchuan Xing; Gregg L Semenza; Ella Liberzon; Andrew Wilson; Tatum S Simonson; Lynn B Jorde; William G Kaelin; Peppi Koivunen; Josef T Prchal
Journal:  Nat Genet       Date:  2014-08-17       Impact factor: 38.330

5.  Enhanced growth of myelodysplastic colonies in hypoxic conditions.

Authors:  James Edwin Thompson; Joseph Patrick Conlon; Xiaowei Yang; Patricia Vanessa Sanchez; Martin Carroll
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

6.  Expansion of human SCID-repopulating cells under hypoxic conditions.

Authors:  Guénahel H Danet; Yi Pan; Jennifer L Luongo; Dominique A Bonnet; M Celeste Simon
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Hypoxia alters progression of the erythroid program.

Authors:  Heather M Rogers; Xiaobing Yu; Jie Wen; Reginald Smith; Eitan Fibach; Constance Tom Noguchi
Journal:  Exp Hematol       Date:  2007-10-22       Impact factor: 3.084

8.  The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells.

Authors:  Maria Grazia Cipolleschi; Elisabetta Rovida; Persio Dello Sbarba
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.

Authors:  Elisabetta Rovida; Ilaria Marzi; Maria Grazia Cipolleschi; Persio Dello Sbarba
Journal:  Hypoxia (Auckl)       Date:  2014-01-21

Review 10.  Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology.

Authors:  Shant Der Sarkissian; Thierry Lévesque; Nicolas Noiseux
Journal:  World J Stem Cells       Date:  2017-01-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.